The decrease in tumor growth may be the only consequence of the decrease in M2-like macrophages, but effects on other immunosuppressive cells cannot be excluded as GRP94 inhibition impacts iC3b and GARP, which are major immunosuppressive effectors. The gene discussed is HSP90B1; the disease is neoplasm.